Gainers & Losers
Thu Apr 17 2025 10:24:08- Icici Bank share price
- ₹1,406.653.68%
- Bharti Airtel share price
- ₹1,889.203.63%
- Sun Pharmaceutical Industr...
- ₹1,751.953.50%
- State Bank Of India share price
- ₹797.103.28%
- Bajaj Finserv share price
- ₹2,033.753.24%
Active Stocks
Thu Apr 17 2025 10:26:25- Wipro share price
- ₹236.90-4.28%
- Tata Steel share price
- ₹137.150.15%
- Bharat Electronics share price
- ₹295.100.48%
- Indian Oil Corp share price
- ₹134.300.34%
- Bank Of Baroda share price
- ₹242.700.75%
Business News/Market/Market Stats/Sun Pharmaceutical Industries share price/ Sun Pharmaceutical Industries Profit Loss Annual
Sun Pharmaceutical Industries Profit & Loss Annual
Trade1,751.95 +59.30 (3.50%)Updated : 17 Apr 2025
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 48,496.85 | 43,885.68 | 38,654.49 | 33,498.14 |
| Total Revenue | 48,496.85 | 43,885.68 | 38,654.49 | 33,498.14 |
| Costof Revenue Total | 12,069.66 | 11,942.42 | 11,707.65 | 9,885.42 |
| Gross Profit | 36,427.19 | 31,943.26 | 26,946.84 | 23,612.72 |
| Selling/ General/ Admin Expenses Total | 22,171.71 | 19,394.87 | 15,945.42 | 14,344.76 |
| Depreciation/ Amortization | 2,556.79 | 2,529.43 | 2,143.74 | 2,079.95 |
| Unusual Expense( Income) | 492.72 | 188.37 | 4,570.27 | 4,307.00 |
| Other Operating Expenses Total | 1,189.04 | 738.24 | 709.74 | 734.39 |
| Total Operating Expense | 38,479.92 | 34,793.33 | 35,076.82 | 31,351.52 |
| Operating Income | 10,016.93 | 9,092.35 | 3,577.67 | 2,146.62 |
| Interest Inc( Exp) Net- Non- Op Total | 1,226.63 | 281.23 | 534.73 | 586.28 |
| Gain( Loss)on Saleof Assets | -9.97 | 7.54 | 34.75 | 13.88 |
| Other Net | -145.70 | 27.31 | 334.17 | 52.59 |
| Net Income Before Taxes | 11,087.89 | 9,408.43 | 4,481.32 | 2,799.37 |
| Provisionfor Income Taxes | 1,439.45 | 847.59 | 1,075.50 | 514.69 |
| Net Income After Taxes | 9,648.44 | 8,560.84 | 3,405.82 | 2,284.68 |
| Minority Interest | -33.65 | -39.36 | -116.55 | 631.47 |
| Equity In Affiliates | -38.41 | -47.90 | -16.54 | -12.33 |
| Net Income Before Extra Items | 9,576.38 | 8,473.58 | 3,272.73 | 2,903.82 |
| Net Income | 9,576.38 | 8,473.58 | 3,272.73 | 2,903.82 |
| Income Availableto Com Excl Extra Ord | 9,576.38 | 8,473.58 | 3,272.73 | 2,903.82 |
| Income Availableto Com Incl Extra Ord | 9,576.38 | 8,473.58 | 3,272.73 | 2,903.82 |
| Diluted Net Income | 9,576.38 | 8,473.58 | 3,272.73 | 2,903.82 |
| Diluted Weighted Average Shares | 239.93 | 239.93 | 239.93 | 239.93 |
| Diluted EPS Excluding Extra Ord Items | 39.91 | 35.32 | 13.64 | 12.10 |
| DPS- Common Stock Primary Issue | 13.50 | 11.50 | 10.00 | 7.50 |
| Diluted Normalized EPS | 41.74 | 36.01 | 28.03 | 26.71 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| period Type | - | - | - | - |
*All figures in crores except per share values
Sun Pharmaceutical Industries Quick Links
Sun Pharmaceutical Industries Dividend Sun Pharmaceutical Industries Bonus Sun Pharmaceutical Industries News Sun Pharmaceutical Industries AGM Sun Pharmaceutical Industries Rights Sun Pharmaceutical Industries Splits Sun Pharmaceutical Industries Board Meetings Sun Pharmaceutical Industries Key Metrics Sun Pharmaceutical Industries Shareholdings Sun Pharmaceutical Industries Balance Sheet Sun Pharmaceutical Industries Cashflow Sun Pharmaceutical Industries Q1 Results Sun Pharmaceutical Industries Q2 Results Sun Pharmaceutical Industries Q3 Results Sun Pharmaceutical Industries Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,406.65+49.90(3.68%)
1,889.20+66.20(3.63%)
1,751.95+59.30(3.50%)
236.90-10.60 (-4.28%)
1,305.85-3.20 (-0.24%)